PraxisUnico 2015 Conference in Dublin
The meeting was attended by Melanie Hardman and Hugh Spotswood. Ximbio had an exhibition stand at the event, but had also sponsored a new initiative for PraxisUnico: a Special Interest Group. This was focused on express licensing and provided an opportunity to bring together the Express Licensing Group ELG (formerly called the Reagents Forum) for its annual meeting. The aim of the ELG session was to share the group’s knowledge and experience to a wider group of Technology Transfer Offices. The session covered what express licensing technologies are and the types of tools available to expedite sourcing and commercialisation of them; for example, Ximbio for research reagents and Isis Outcomes for software and clinical outcome assessments (COA).
On the day
As always PraxisUnico had set-up the exhibitor area amongst the food and drink, which meant there was some great footfall to the booth. Hugh and Melanie were consistently talking to other delegates about the services Ximbio can offer for life science reagent commercialisation, and in total engaged with over 30 different institutes.
Express Licensing Group (ELG)
Melanie chaired and presented the Special Interest Group on Friday morning. The session went very smoothly; all the speakers kept to time and had some very interesting questions. The talks covered:
The talks included:
* "What are Express Licensed Products?", in which David Churchman, Isis Innovation Ltd, discussed supporting health outcomes research through express licensing
* "Express IP: From Coalface to Marketplace", delivered by Ed Maughfling of UMIP
* "Tools to Enable Express Licensing", in which I described how Ximbio can make research tools widely and easily available.
* "E-lucid – mining the IP long tail", a talk by Marina Santilli of UCLB about how UCLB uses its online licensing portal to good effect
There was further discussion during the panel session. Hugh represented Ximbio and was joined by Peter Thraves (Collection of European Cell Cultures (ECACC), part of Public Health England), Chris Arnot (Cambridge Enterprise), Stephen Brett (Anderson Law) and Ed Maughfling (UMIP).
The panellists discussed other ways that university Technology Transfer Offices source express licensing products from their researchers, how much due diligence should be done on low value/no value IP and how Technology Transfer Offices can work better with ECACC when depositing cell lines. Hugh also spoke about different types of deal structures for maximising express IP products.
If you are interested in joining the Express Licensing Group, please contact Melanie Hardman.
HAVE YOU REGISTERED?
Join theever-growing global Ximbio community.Register and receive updates about new reagents, institutes and new featuresbeing added to the website.